Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force—Part 2: Specific treatment recommendations
Journal of the European Academy of Dermatology and Venereology · 2023-11 · 37 (11) · 2185-2195
DOI: 10.1111/jdv.19450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 15.09.2023. Verfasst von Julien Seneschal und 45 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, ImmunoConcept, CNRS UMR…. Hauptthemen laut MEDLINE: Vitiligo, Ultraviolet Therapy, Photochemotherapy. Die Arbeit wurde bisher 177-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The treatment of vitiligo can be challenging. Up‐to‐date agreed consensus recommendations on the use of topical and systemic therapies to facilitate the clinical management of vitiligo are currently lacking.
Objectives
To develop internationally agreed‐upon expert‐based recommendations for the treatment of vitiligo.
Methods
In this consensus statement, a consortium of 42 international vitiligo experts and four patient representatives participated in different online and live meetings to develop a consensus management strategy for vitiligo. At least two vitiligo experts summarized the evidence for different topics included in the algorithms. A survey was then given to a core group of eight experts to resolve the remaining issues. Subsequently, the recommendations were finalized and validated based on further input from the entire group during two live meetings.
Results
The recommendations provided summarize the latest evidence regarding the use of topical therapies (steroids, calcineurin inhibitors and Jak‐inhibitors) and systemic therapies, including steroids and other systemic immunomodulating or antioxidant agents. The different modalities of phototherapies (NB‐UVB, photochemotherapy, excimer devices and home phototherapy), which are often combined with other therapies, are also summarized. Interventional approaches as well as depigmentation strategies are presented for specific indications. Finally, the status of innovative and targeted therapies under development is discussed.
Conclusions
This international consensus statement culminated in expert‐based clinical practice recommendations for the treatment of vitiligo. The development of new therapies is ongoing in vitiligo, and this will likely improve the future management of vitiligo, a disease that still has many unmet needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, ImmunoConcept, CNRS UMR 5164, Bordeaux University, Bordeaux, France.
- Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
- Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, BRIC, UMR 1312, Inserm, University Bordeaux, Bordeaux, France.
- Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Dermatology, University Hospital of Nice, Nice, France.
- Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
ORCID-Profile: Julien Seneschal, Alain Taïeb, Thierry Passeron, Amit G Pandya, Khaled Ezzedine, Flora Xiang, Atsushi Tanemura, Michelle Rodrigues, Davinder Parsad, Naoki Oiso, Eric Lan, Sang Ho Oh, Somesh Gupta, Markus Böhm, Laila Benzekri, Jung Min Bae, Marwa Abdallah, Nanja van Geel
Zitieren
APA
Seneschal, J., Speeckaert, R., Taïeb, A., Wolkerstorfer, A., Passeron, T., Pandya, A. G., Lim, H. W., Ezzedine, K., Zhou, Y., Xiang, F., Thng, S., Tanemura, A., Suzuki, T., Rosmarin, D., Rodrigues, M., Raboobee, N., Pliszewski, G., Parsad, D., Oiso, N., …, & van Geel, N. (2023). Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force—Part 2: Specific treatment recommendations. Journal of the European Academy of Dermatology and Venereology, 37(11), 2185-2195. https://doi.org/10.1111/jdv.19450
Vancouver
Seneschal J, Speeckaert R, Taïeb A, Wolkerstorfer A, Passeron T, Pandya AG, et al. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force—Part 2: Specific treatment recommendations. Journal of the European Academy of Dermatology and Venereology. 2023;37(11):2185-2195. doi:10.1111/jdv.19450
BibTeX
@article{Seneschal2023,
author = {Seneschal, Julien and Speeckaert, Reinhart and Taïeb, Alain and Wolkerstorfer, Albert and Passeron, Thierry and Pandya, Amit G and Lim, Henry W and Ezzedine, Khaled and Zhou, Youwen and Xiang, Flora and Thng, Steven and Tanemura, Atsushi and Suzuki, Tamio and Rosmarin, David and Rodrigues, Michelle and Raboobee, Noufal and Pliszewski, Georg and Parsad, Davinder and Oiso, Naoki and Monteiro, Paul and Meurant, Jean Marie and Maquignon, Nicolle and Lui, Harvey and Le Poole, Caroline and Leone, Giovanni and Lee, Ai-Young and Lan, Eric and Katayama, Ichiro and Huggins, Richard and Oh, Sang Ho and Harris, John E and Hamzavi, Iltefat H and Gupta, Somesh and Grimes, Pearl and Goh, Boon Kee and Ghia, Deepti and Esmat, Samia and Eleftheriadou, Viktoria and Böhm, Markus and Benzekri, Laila and Bekkenk, Marcel and Bae, Jung Min and Alomar, Augustin and Abdallah, Marwa and Picardo, Mauro and van Geel, Nanja},
title = {Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force—Part 2: Specific treatment recommendations},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2023},
volume = {37},
number = {11},
pages = {2185--2195},
doi = {10.1111/jdv.19450}
}
EUVIMED